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OBJECTIVE: The aim of this study was to characterize Staphylococcus aureus (MRSA) carriage in a dermatology unit.
METHODS: This was a prospective and descriptive study. Over the course of 26 weeks, surveillance cultures were
collected weekly from the anterior nares and skin of all patients hospitalized in a 20-bed dermatology unit of a
tertiary-care hospital. Samples from healthcare workers (HCWS) were cultured at the beginning and end of the
study. Colonized patients were put under contact precautions, and basic infection control measures were enforced.
Staphylococcus aureus colonization pressure was determined monthly. Colonized and non-colonized patients were
compared, and isolates were evaluated for antimicrobial susceptibility, SCCmec type, virulence factors, and type.
RESULTS: Of the 142 patients evaluated, 64 (45%) were colonized by MRSA (39% hospital acquired; 25%
community acquired; 36% indeterminate). Despite isolation precautions, hospital-acquired Staphylococcus
aureus occurred in addition to the continuous entry of Staphylococcus aureus from the community. Colonization
pressure increased from 13% to 59%, and pemphigus and other bullous diseases were associated with MRSA
colonization. Eleven out of 71 HCWs (15%) were Staphylococcus aureus carriers, although only one worker
carried a persistent clone. Of the hospital-acquired MRSA cases, 14/28 (50%) were SCCmec type IV (3 PFGE types),
13 were SCCmec type III (46%), and one had an indeterminate type. These types were also present among the
community-acquired Staphylococcus aureus isolates. SSCmec type IV isolates were shown to be more susceptible
than type III isolates. There were two cases of bloodstream infection, and the pvl and tst virulence genes were
absent from all isolates.
CONCLUSIONS: Dermatology patients were colonized by community- and hospital-acquired Staphylococcus aureus.
Half of the nosocomial Staphylococcus aureus isolates were SCCmec type IV. Despite the identification of colonized
patients and the subsequent contact precautions and room placement, Staphylococcus aureus colonization
continued to occur, and colonization pressure increased. Pemphigus and other bullous diseases were associated
with Staphylococcus aureus.
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INTRODUCTION
Staphylococcus aureus is a versatile pathogen capable of
causing a wide variety of infections.1 The prevalence of
nosocomial and community-acquired methicillin-resistant
Staphylococcus aureus (MRSA) infections has increased in
recent years.2 Methicillin resistance of Staphylococcus aureus
is mediated by a penicillin-binding protein (PBP2A) that has
a low affinity for b-lactam antibiotics and is encoded by the
mecA gene.3,4 This gene is carried on a mobile genetic
element designated as Staphylococcal Cassette Chromo-
some mec (SCCmec), which is integrated into the chromo-
some. Currently, 11 types of SCCmec have been reported.5-7
In healthcare settings, patients who are colonized by or
infected with MRSA serve as a reservoir and a source for
the spread of this microorganism, which occurs mainly th-
rough transiently colonized healthcare workers (HCWs).8,9
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Carriage of S. aureus is considered a risk factor for the
development of infections, as infections are usually pre-
ceded by a period of colonization.10
The objective of this study was to characterize MRSA
carriage in a hospital dermatology unit.
METHODS
Hospital das Clı´nicas is a tertiary-care teaching hospital
that is affiliated with the University of Sa˜o Paulo, Brazil. It
has approximately 2,000 beds and is divided into 6
buildings. The dermatology unit has 20 beds, which are
distributed across 10 rooms of one, two, or four beds each.
This unit is used for the hospitalization of patients with
severe dermatologic conditions. On average, there are 30
admissions per month and 4,500 patient-days each year.
Surveillance cultures of patients
Over a period of 26 weeks that began on May 31, 2005,
weekly surveillance cultures for MRSA were obtained from
all of the patients admitted to the unit. These samples were
collected from the anterior nares and skin lesions. Patients
who were positive for MRSA were not followed for further
surveillance cultures. Patients who were negative for
MRSA were cultured weekly until their discharge from
the unit.
Due to the high proportion of patients who tested positive
on the first surveillance culture, patients were cultured
upon admission and then weekly from the 13th week of the
study onward.
The swabs from the anterior nares were collected by
introducing a swab into the nasal vestibulum and then
rubbing with light pressure. The swabs were transported in
sterile tubes containing culture medium and were sent
immediately to the laboratory for further processing and
analysis. The swabs from skin lesions were collected by
gently scraping or rolling the swab across the lesion.
Definitions
Nosocomial acquisition of MRSA was defined as a
positive culture in a patient who had been in the hospital
for more than 48 hours and whose previous surveillance
cultures at both sites had been negative (nares and skin).
For patients who were positive within the first 48 hours of
hospitalization, MRSA was considered to have been present
at the time of hospital admission. All other colonizations
were considered indeterminate as to where MRSA acquisi-
tion occurred.
The following patient data were registered upon admis-
sion to the study: age, sex, date of admission to the hospital,
underlying diseases, hospitalization within the previous 12
months, and use of antimicrobial drugs. The patients were
followed until their discharge from the unit. We evaluated
the colonization of the patients by dividing the study into
six periods.
Control measures
All patients positive for MRSA were placed in separate
rooms or were placed in a cohort with other MRSA carriers
and put under contact precautions until hospital discharge
or death. Hand hygiene was enforced by requiring the
use of alcohol gel. There were two educational meetings
with members of the staff in which the control measures
and their objectives were discussed. Posters were spread
throughout the unit to report the weekly number of
patients colonized by MRSA. Patients also received
information regarding the contact precautions and their
importance.
Surveillance cultures of healthcare workers (HCWs)
The anterior nares of the healthcare workers were
cultured on two occasions: at the beginning and at the end
of the study. HCWs who tested positive were not treated.
Ethics
The study protocol followed the ethical guidelines of the
1975 Declaration of Helsinki and was approved by the
Ethics Commission of the Hospital das Clı´nicas (approval
number: 1072/04).
Analysis of data
Continuous variables are herein presented as the means
¡ standard deviation or median and range. Frequencies
were calculated for the categorical variables. MRSA-colo-
nized patients were compared to non-colonized patients
using the x2 test for categorical variables and the Mann
Whitney test for continuous variables. The data were
analyzed using Epi Info 6.04 software (CDC, Atlanta,
USA). A p-value of 0.05 was considered statistically
significant.
For each period, we determined the total number of
patient-days and the number of MRSA patient-days (by
summing the days that each MRSA-colonized patient
remained in the unit after the day that MRSA colonization
was first identified). Colonization pressure was also
determined for each period by dividing the number of
MRSA patient-days by the total number of patient-days
(expressed as a percentage).
Microbiological methods
Detection of MRSA. Samples were plated onto mannitol
salt agar (MSA) and inoculated into brain heart infusion
(BHI) broth. Mannitol-fermenting colonies were subcul-
tured onto 5% sheep blood agar plates. If the initial MSA
culture was negative, a subculture from the BHI broth was
carried out on MSA plates to increase the sensitivity of
detection. S. aureus was identified by Gram staining and
DNAse and catalase tests. Methicillin resistance was
determined using Mueller Hinton agar supplemented with
4% NaCl and 6 mg/mL oxacillin according to guidelines of
the Clinical Laboratory Standards Institute (CLSI).11 If there
was growth of at least one colony-forming unit, the culture
was considered positive. S. aureus ATCC 29213 and NCTC
10442 were used as controls.
The phenotypic identification was confirmed by poly-
merase chain reaction (PCR), amplifying 117 bp and 214 bp
fragments from the coagulase and mecA genes, respectively,
using the NCL-SA-PS kit (Novo Castra, United Kingdom),
as previously described by Kearns et al.12
Susceptibility testing. Minimal inhibitory concentrations
(MICs) were determined using the broth microdilution me-
thod and were interpreted according to CLSI guidelines11,13
for oxacillin, penicillin, chloramphenicol, ciprofloxacin, clinda-
mycin, erythromycin, gentamicin, rifampicin, sulfametho-
xazole/trimethoprim, tetracycline and vancomycin.
Molecular typing. Molecular typing was performed by
digesting whole-cell DNA with the SmaI macrorestriction
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enzyme (Fermentas Life Sciences, Canada) and then
determining the fragment-size patterns obtained with
pulsed-field gel electrophoresis (PFGE) using a CHEF DR-
II apparatus (Bio-Rad Laboratories, USA).14 The patterns
were analyzed as recommended by Tenover et al.15 Types
were defined as isolates that differed by at least seven
fragments and were identified using letters. Subtypes of a
given clonal type were defined as those isolates that differed
by fewer than seven fragments and were identified using
numbers.
Multilocus sequence typing was performed for 10 isolates
according to methods described elsewhere.16 This sequence
typing was performed for one isolate of each PFGE type
(seven isolates), one isolate for which the SCCmec type could
not be determined and two isolates in which mecA could not
be detected.
SCCmec typing. The determination of the SCCmec type
was performed using the multiplex PCR method, as
described by Oliveira & Lencastre.17 DNA was extracted
using a commercial kit (Genomic Prep Cells and Tissue
DNA Isolation, Amersham Pharmacia, Biotech, Germany).
PCR amplifications were performed using a GeneAmp PCR
System 2400 thermocycler (Perkin-Elmer, Waltham, MA,
USA). The MRSA strains NTCT 10442, N315, 85/2082 and
JSCS 1968, which belong to SCCmec types I, II, III, and IV,
respectively, were used as positive controls.
Detection of genes for virulence factors. One isolate
from each PFGE subtype was evaluated for the Panton
Valentine leukocidin (pvl), LukE-LukD leukocidin (lukE-
lukD) and toxic shock syndrome toxin-1 (tst) virulence genes
by PCR using primers described elsewhere.18 Briefly,
samples were denatured for 5 minutes at 94 C˚; subjected
to 30 cycles of denaturation at 95 C˚ for 30 seconds,
annealing at 55 C˚ for 1 minute, and extension at 72 C˚ for
2 min; and then subjected to a final extension at 72 C˚ for 5
minutes. The MR108 (positive for pvl) and N315 (positive for
lukE-lukD and tst) isolates were used as controls.
RESULTS
During the study period, 153 patients were admitted to
the dermatology unit. Of these, 11 were lost to follow-up,
and 142 were evaluated until discharge and included in the
analysis.
Of the 142 patients, 64 (45%) were colonized by MRSA.
There were 26 patients who were positive only from the
culture of the anterior nares (one patient harbored two
isolates), 11 who were positive only from skin culture and
27 who had tested positive from both sites (two patients
each harbored three isolates). Thus, 94 MRSA isolates from
64 patients were microbiologically evaluated.
Among the 64 patients (45%) who were colonized by
MRSA, 25 (39%) had hospital-acquired infections, 16 (25%)
were colonized at the time of admission and 23 patients
(36%) had an indeterminate site of acquisition. The
distributions over time of patients who were colonized at
the time of admission and of those who acquired MRSA in
the hospital are presented in Figure 1. Despite the control
measures, the nosocomial acquisition of MRSA occurred
during the entire study period. In addition, during the
entire study period, there was a continuous entry of patients
who were MRSA positive at the time of admission, and the
Figure 1 - The monthly distribution of patients colonized by MRSA at the time of admission, the distribution of patients who acquired
MRSA in the hospital and the MRSA colonization pressure in the dermatology unit over a 6-month period.
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colonization pressure also increased over the six-month
study period (Figure 1).
The characteristics of the MRSA-colonized and non-
colonized patient populations are presented in Table 1.
Bullous diseases, such as pemphigus and others, were
significantly more frequent among colonized patients.
The SCCmec types and molecular types of the 94 isolates
were determined. When a patient harbored more than one
isolate of the same SCCmec type and PFGE type, only one
isolate for that patient was included in the final analysis.
Therefore, 67 isolates from 64 patients were analyzed. There
were seven molecular PFGE types (A to G) that were
divided into 30 subtypes. The distribution of the patient
isolates according to the origin of acquisition, SCCmec type
and molecular type is presented in Table 2. The results of
the MLST for isolates of each PFGE type (A to G) are
presented in Table 3.
The SCCmec type IV isolates belonged to four different
PFGE molecular types (A-D) and four different sequence
types (ST5, ST8, ST97 and ST1176). However, the PFGE type
and ST did not correlate completely, as ST8 belonged to two
different PFGE types (B and D), and there were 2 ST (ST97
and ST5) among the isolates of PFGE type C.
Of the SCCmec type III isolates, there were 3 PFGE
molecular types (E-G), all of which belonged to ST239, as
does the multiresistant Brazilian Endemic Clone (BEC).
Of the isolates obtained at the time of patient admission,
most were SCCmec type IV, but there were also four isolates
that were similar to the BEC.
The hospital-acquired isolates were evenly distributed
among SCCmec types IV and III.
Among the 30 isolates tested (all carried SCCmec type IV),
the pvl and tst virulence factors were absent from all of
them, and the lukD-lukE gene was present in all of them.
During the study period, there were two cases of
bloodstream infections. These were caused by MRSA of
SCCmec type IV and PFGE type A. These patients had been
colonized by the same subtypes at earlier time points (25
and 40 days prior).
Thirty-seven healthcare workers (HCWs) were cultured at
the beginning of the study, and 34 were cultured at the end
of the study. Of these, five (14%) were positive on the first
occasion, and six (18%) were positive on the second. The
distribution of the isolates from healthcare workers accord-
ing to SCCmec type and molecular type is presented in
Table 4. Fifteen HCWs were cultured on both occasions, and
three were positive on both occasions, but only one
healthcare worker (belonging to the housekeeping staff)
presented the same subtype twice (C3). However, none of
the patients presented the C3 subtype.
The antimicrobial susceptibilities of the isolates that
colonized 60 patients and 11 healthcare workers are shown
in Table 5.
DISCUSSION
Colonization with MRSA was prevalent among patients
hospitalized for dermatological diseases (45%), and this
colonization was due to both hospital acquisition and
colonization prior to admission.
This study began by examining routine surveillance
cultures to determine the extent of the problem and to
identify patients who should be placed under contact
precautions, such as placement in a private room or in a
patient cohort. Through the enforcement of these measures,
we expected to halt the nosocomial transmission of MRSA.
Community-acquired MRSA (CA-MRSA) has been rarely
described in Brazil and has been shown to occur mainly in
Table 1 - Characteristics of MRSA-colonized patients and non-colonized patients in the dermatology unit over a 6-
month period.
Characteristics Colonized (n= 64) Non-colonized (n =78) p-value
n (%) n (%)
Male sex 28 (44%) 37 (47%) 0.66
Age (years)
-mean (SD)
-median (range)
42.8 (21.8)
42 (1-84)
38.8 (25.7)
35 (0-92)
0.33
Total days of hospitalization
-mean (SD)
-median (range)
24.3 (20.8)
17 (2-118)
15.4 (24.4)
8.5 (1-168)
0.02
Days of hospitalization until MRSA detection
-mean (SD)
-median (range)
9.5 (10.4)
6 (0-49)
NA
NA
Hospitalization within the previous 12 months
-in our hospital
30 (47%)
18 (60%)
25% (32%)
15 (60%)
0.07
0.21
Previous use of antimicrobial drugs 38 (59%) 36 (46%) 0.12
Underlying diseases
Bullous diseases 22 (34%) 6 (8%) ,0.001
Pemphigus 15 (23%) 3 (4%) ,0.001
Other bullous 7 (11%) 3 (4%) 0.10
Atopy 11 (17%) 10 (13%) 0.47
Cancer 5 (8%) 9 (12%) 0.46
Erythrodermia 8 (13%) 6 (8%) 0.34
Infectious 7 (11%) 8 (10%) 0.90
Auto-immune 4 (6%) 8 (10%) 0.10
Psoriasis 6 (9%) 8 (10%) 0.86
Eczema - 7 (9%) 0.14
Death during hospitalization 4 (6%) 1 (1%) 0.11
SD: standard deviation NA: not applicable.
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the southern region of the country19, 20 near the border with
Uruguay, which is a country in which CA-MRSA is a
significant problem. In addition, in a previous study of
MRSA isolates obtained from bloodstream infections,21
there were six cases of hospital-acquired MRSA bacteremia
the dermatology unit. Thus, we expected most of the cases
of MRSA colonization to be hospital acquired. However, in
our dermatology unit, we observed that approximately half
of the colonization cases were hospital-acquired and that a
significant proportion of patients were positive for MRSA at
the time of admission. Our results suggest that many
patients are colonized by community-acquired MRSA or are
colonized at other healthcare facilities and may be a source
of MRSA transmission to other patients in the hospital.
There was a significantly higher proportion of patients with
pemphigus and other bullous diseases among MRSA
carriers, which suggested that disseminated bullous disease
is a risk factor for MRSA colonization.
During the entire study period, nosocomial transmission
of MRSA occurred as well as admission of colonized
patients. This likely generated or increased colonization
pressure and made control more difficult despite the efforts
directed to prevent nosocomial MRSA transmission. Over
the six-month study period, the frequency of nosocomial-
acquired cases tended to decrease, but the colonization
pressure increased from 13% to 59%. We attributed this
decrease in the nosocomial acquisition of MRSA to the
extensive efforts of the staff, which included improving the
isolation conditions and the infection control measures. Our
original goal was the complete eradication of nosocomial
transmission, but this goal was not achieved. The coloniza-
tion pressure was first evaluated for vancomycin-resistant
enterococci.22 This type of resistance has been studied in
MRSA and has been shown to play a role as a risk factor for
nosocomial transmission.23 In one study, a colonization
pressure above 30% led to a 5-fold increase in the risk of
MRSA colonization.24
Due to the large number of patients who are colonized at
the time of admission, the use of routine surveillance
cultures and the placement of colonized patients into
cohorts may not affect the rates of colonization unless all
patients are immediately placed under contact precautions
even before the surveillance cultures are analyzed.
Furthermore, the success of MRSA control that is based
mainly on the identification of carriers through the analysis
of surveillance cultures depends on the sensitivity of these
cultures, which may not be sufficiently high to detect all
colonized patients. Some authors have reported that the lack
of throat culturing may lead to an underestimation of the
percentage of MRSA carriers by as much as 8 to 18%.25, 26
The clinical impact and the relevance of routine patient
culturing may be contested because, despite a high
proportion of colonized patients, there were only two cases
of bloodstream infection in our six-month study period.
Routine culturing and the use of patient cohorts and private
rooms for positive patients are expensive and labor-
intensive measures. In our hospital, most rooms are meant
to hold two or four patients, and there are very few private
rooms. During patient isolation, the rooms are not used at
full capacity, which is a problem because there is a
nationwide shortage of hospital beds. In addition, although
the carriage of S. aureus is considered a risk factor for the
development of infection,10 one prospective study found
that nasal colonization with MRSA was a poor predictor of
the subsequent occurrence of MRSA respiratory tract or
bloodstream infection.27
This study also addressed the role of HCWs in the
transmission of MRSA. Among HCWs, MRSA was observed
in 15% of the cultures. Only three HCWs were positive on
both occasions, but two HCWs harbored different molecular
types of MRSA at each culture, suggesting transient
carriage. Interestingly, half of the HCWs who were positive
for MRSA harbored isolates of subtypes that were not
present among the patients. This result suggests that a large
Table 2 - SCCmec type and molecular type of 67 MRSA
isolates according to the origin of acquisition.
Origin of the MRSA (n)
SCCmec
type (n)
Molecular
PFGE type (n)
Hospital acquired (n: 28) III (13) E (9)
F (2)
G (2)
IV (14) B (6)
A (5)
C (3)
ND (1) C (1)
Positive at hospital admission (n:16) III (4) E (4)
IV (11) A (7)
C (4)
ND (1) C (1)
MRSA: methicillin-resistant S. aureus; PFGE: pulsed-field gel
electrophoresis; ND: not determined.
Table 3 - Multilocus sequence typing results for 10
methicillin-resistant S. aureus subtypes that colonized
patients hospitalized in the dermatology unit over a
period of 6 months.
Subtype determined by PFGE Sequence type SCCmec type
A1 1176 IV
B1 8 IV
C1 97 IV
C6 5 ND
D 8 IV
E1 239 III
E8 239 -
E9 239 -
F 239 III
G 239 III
PFGE: pulsed-field gel electrophoresis; SCCmec: staphylococcal
chromosomal cassette mec; ND: not determined; -: absence of mecA.
Table 4 - The SCCmec and molecular types of 11 MRSA
isolates obtained from healthcare workers at the
beginning and the end of the study.
Healthcare workers
SCCmec
type (n)
Molecular
PFGE type (n)
Beginning of study (n: 37) 5 (14%)
positive for MRSA
IV (5) C (3)
B (1)
A (1)
End of study (n: 34) 6 (18%) positive for
MRSA
IV (5)
III (1)
A (1)
B (3)
C (1)
E (1)
MRSA: methicillin-resistant S. aureus; PFGE: pulsed-field gel
electrophoresis.
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proportion of the HCW colonizations were acquired outside
of the hospital, either in the community or at other
institutions.
MRSA with SCCmec type III was multidrug resistant and
belonged to the Brazilian Endemic Clone (BEC). Molecular
typing by pulsed-field gel electrophoresis (PFGE) revealed
three different types and one predominant type (79%).
Within this predominant type, there were nine different
subtypes. The BEC has been endemic in Brazil for more than
a decade.28 During this time, it is likely that changes
occurred that made Tenover’s criteria17 inadequate to
interpret its clonality. In this situation, multilocus sequence
typing (MLST) is more useful because it evaluates seven
housekeeping genes that are more stable over time.29 BEC
presents as sequence type ST-239,28 and all of the SCCmec
type III isolates tested in our study also belonged to this ST.
The presence of MRSA with SCCmec type IV at our
hospital is a more recent phenomenon than the existence of
the BEC. Therefore, the PFGE typing reflected clonality that
was similar although not identical to the MLST.21
Furthermore, we expected that the SCCmec type IV would
be mainly community acquired. However, similar to other
geographic areas,30 it seems as though this type has crossed
hospital borders and circulates not only in the community
but also in the hospital environment.
As observed in other studies conducted at our hospi-
tal,21,31 SCCmec type IV MRSA isolates from dermatologic
patients did not express the Panton-Valentine leukocidin
(PVL) virulence factor. The tst gene was also absent from all
of the isolates. This finding is interesting because PVL-
producing clones have been associated with skin and soft
tissue infections32,33 and because TSST-1 is the cause of skin
lesions. On the other hand, in a hospital environment, where
patients are severely ill and have many diseases, a virulent
strain of S. aureus would probably not be successful because
it would cause severe infection and high mortality, as it does
in the community.
Our study has limitations. First, it was our original
intention to use the CDC definitions, but the necessary
information was not available for a large proportion of the
included patients. Because of this lack of information, we
had to introduce the ‘‘indeterminate’’ category. There was
a large proportion of patients for which the origin of
colonization was deemed indeterminate, which was in part
due to the fact that surveillance culturing immediately upon
admission was only initiated halfway into the study. In
addition, we did not observe SCCmec types other than types
I to IV, and there were a few isolates for which we could not
determine the type. Finally, it was not possible to perform
MLST analyses on each of the PFGE subtypes.
In summary, almost half of the dermatology patients in
this study were colonized by MRSA at the time of hospital
admission or acquired MRSA while in the hospital. Half
of the nosocomial MRSA cases were SCCmec type IV.
Nosocomial MRSA colonization continued throughout the
study period despite the identification of colonized patients,
the use of contact precautions and patient cohorting or the
placement of patients in private rooms based on their
surveillance cultures. Colonization pressure continuously
increased during the study period, which may partly
explain the difficulty in controlling the spread of MRSA.
Pemphigus and other bullous diseases were significantly
associated with MRSA colonization. The healthcare workers
were predominantly colonized by SCCmec type IV MRSA,
and this colonization was found to be transient and
predominantly community acquired.
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